Evidence map›Paper›PMID 32343625›Full record

ArticleThe American journal of drug and alcohol abuse2020

Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.

Aaron C Lim, Erica N Grodin, Rejoyce Green, Alexandra Venegas, Lindsay R Meredith, Kelly E Courtney, Nathasha R Moallem, Philip Sayegh, Edythe D London, Lara A Ray

Open access · greenAbstract read
In one paragraph

Article in The American journal of drug and alcohol abuse, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Aaron C LimDepartment of Psychology, University of California , Los Angeles, CA, USA.ORCID 0000-0003-2575-5226
Erica N GrodinDepartment of Psychology, University of California , Los Angeles, CA, USA.
Rejoyce GreenDepartment of Psychology, University of California , Los Angeles, CA, USA.
Alexandra VenegasDepartment of Psychology, University of California , Los Angeles, CA, USA.ORCID 0000-0002-6679-8954
Lindsay R MeredithDepartment of Psychology, University of California , Los Angeles, CA, USA.
Kelly E CourtneyDepartment of Psychology, University of California , San Diego, CA, USA.
Nathasha R MoallemDepartment of Psychology, University of California , Los Angeles, CA, USA.
Philip SayeghDepartment of Psychology, University of California , Los Angeles, CA, USA.
Edythe D LondonDepartment of Psychiatry and Biobehavioral Sciences, University of California , Los Angeles, CA, USA.
Lara A RayDepartment of Psychology, University of California , Los Angeles, CA, USA.
University of California, Los Angeles · USUniversity of California San Diego · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
UCLA DRUG ABUSE RESEARCH TRAINING PROGRAMT32DA007272 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRELLA, CHRISTINE E · 1991 to 2017
$4.9M
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use DisorderR01AA026190 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAY, LARA A. · 2018 to 2021
$2.7M
Clinical Neuroscience of Alcoholism: Integrating Neuroscience and Clinical TrialsK24AA025704 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY · 2018 to 2026
$1.3M
Pharmacogenetics of Natlrexone for Methamphetamine Use DisorderR21DA029831 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAY, LARA A. · 2011 to 2013
$478k
Elucidating the Effects of Neuroimmune Modulation on Neural Substrates of Alcohol Cue and Stress ReactivityF32AA027699 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRODIN, ERICA N · 2019 to 2020
$103k
NCATS NIH HHS UL1 TR001881NIAAA NIH HHS F32 AA027699NIAAA NIH HHS K24 AA025704NIAAA NIH HHS R01 AA026190NIDA NIH HHS R21 DA029831NIDA NIH HHS T32 DA007272NIDA NIH HHS T32 DA024635
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Executive FunctionAdultAmphetamine-Related DisordersCentral Nervous System StimulantsCognitionCravingCross-Over StudiesDouble-Blind MethodFemaleHumansLos AngelesMaleMethamphetamineNaltrexoneNarcotic AntagonistsYoung AdultCentral Nervous System StimulantsMethamphetamineNaltrexoneNarcotic Antagonistscravingexecutive functionMethamphetaminenaltrexonesubstance use disorder

Identifiers

PMID32343625
PMCPMC7920534
OpenAlexW3019241079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.